Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 September;76(9) > Minerva Anestesiologica 2010 September;76(9):737-43

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS   Free accessfree

Minerva Anestesiologica 2010 September;76(9):737-43

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection?

Lukaszewicz A. C., Faivre V., Payen D.

Laboratory of Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Lariboisière Hospital, APHP, University of Paris 7 Diderot, Paris, France


PDF


Downregulation of the immune response is common among Intensive Care Unit (ICU) patients after an acute inflammatory injury, whether it was septic or not. Such a modification could be seen as an adaptation to attenuate the effects of the inflammatory storm on tissues, but it exposes the subject to the risk of nosocomial infection and impairs recovery processes. The intensity of immunity downregulation is difficult to characterize, since clinical presentation is silent and non-specific, which urges the use of tools for immune monitoring. This review focuses on the use of monocyte HLA-DR expression to detect immune hyporesponsiveness and to select the appropriate immunomodulating therapy, as well as the efficiency of this technique in controlling secondary infections.

top of page